PICI Network Researchers Featured at Spotlight on Immuno-Oncology Conference
July 17, 2023
Six members of the Parker Institute for Cancer Immunotherapy (PICI) Network will present at the 2023 Spotlight on Immuno-Oncology conference, Aug. 1 and 2 in Seattle and online.Hosted by the American Society of Gene & Cell Therapy (ASGCT), the event will focus on novel CAR designs and approaches beyond B-cell malignancies, genome and epigenome editing, direct in vivo delivery for cancer immunotherapy, and other topics.The six PICI Network presenters, in order of their presentations, are:
- Carl H. June, MD, Center Director of PICI at the University of Pennsylvania
- Robbie Majzner, MD, of Stanford Medicine
- Yvonne Y. Chen, PhD, of the University of California, Los Angeles
- Christopher A. Klebanoff, MD, of Memorial Sloan Kettering Cancer Center
- Justin Eyquem, PhD, of the University of California, San Francisco (UCSF)
- Kole Roybal, PhD, also of UCSF
Below are details about their presentations. All times are Pacific Daylight Time. Livestream and on-demand video options also are available.Programming is subject to change. For the most current information, visit the conference agenda. Follow the meeting live on Twitter using the hashtag #IO23ASGCT.
Tuesday, Aug. 1
Session: B-Cell Malignancies and Beyond
Presenter: Carl H. June, MD (Twitter: @CarlHJune)Topic: CAR T Cell Clinical TrialsTime: 9-9:25 a.m.
Session: Novel CAR Designs and Approaches
Presenter: Robbie Majzner, MD (Twitter: @Majzner_Lab)Topic: Novel CAR DesignsTime: 10:15-10:40 a.m.
Presenter: Yvonne Y. Chen, PhDTopic: Engineering Next-Generation CAR-T Cells for Cancer ImmunotherapyTime: 11:05-11:30 a.m.
Session: TCRs
Presenter: Christopher A. Klebanoff, MDTopic: Immunogenicity and Therapeutic Targeting of Recurrently Mutated “Public” Neoantigens Using TCR Gene TherapyTime: 1:50-2:15 p.m.
Wednesday, Aug. 2
Session: Genome and Epigenome Editing for Cancer Immunotherapy
Presenter: Justin Eyquem, PhD (Twitter: @J_Eyquem)Topic: Bridging Synthetic Immunology and Genome Editing to advance T Cell Therapies Time: 8:25-8:50 a.m.
Presenter: Kole Roybal, PhD (Twitter: @KoleRoybal)Topic: To be publicizedTime: 9:15-9:40 a.m.